Showing results (341-350 of 353) with videos related to
Sort By:
Pageof 36
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre studyMichele Bartoletti, Lorenzo Marconi, Luigia Scudeller, et al.Clinical Breast Cancer|June 7, 2025
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International StudySoraia Lobo-Martins, Veronique Debien, Elisa Agostinetto, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2020
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.Infection|October 24, 2013
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patientsM T Montagna, G Lovero, C Coretti, et al.Scientific Reports|December 18, 2020
Infectious and non-infectious diseases burden among Haitian immigrants in Chile: a cross-sectional studyFrancisco Fuster, Felipe Peirano, José Ignacio Vargas, et al.Scientific Reports|December 11, 2025
Identifying priority wetland sites in the East Asian-Australasian Flyway for migratory bird conservationMike Crosby, Shelby Q W Wee, Ding Li Yong, et al.Cancer Biology & Therapy|November 8, 2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer StudyTeresa Gamucci, Laura Pizzuti, Clara Natoli, et al.Journal of Experimental & Clinical Cancer Research : CR|December 11, 2020
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER StudyGiulia Bon, Laura Pizzuti, Valentina Laquintana, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 27, 2024
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohortLoreta A Kondili, Giuseppina Brancaccio, Maria Elena Tosti, et al.World Journal of Emergency Surgery : WJES|February 20, 2020
A proposal for a comprehensive approach to infections across the surgical pathwayMassimo Sartelli, Leonardo Pagani, Stefania Iannazzo, et al.Pageof 36